These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23554686)

  • 1. MiR-148a inhibits angiogenesis by targeting ERBB3.
    Yu J; Li Q; Xu Q; Liu L; Jiang B
    J Biomed Res; 2011 May; 25(3):170-7. PubMed ID: 23554686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-148a Suppresses the Proliferation and Migration of Pancreatic Cancer Cells by Down-regulating ErbB3.
    Feng H; Wang Y; Su J; Liang H; Zhang CY; Chen X; Yao W
    Pancreas; 2016 Oct; 45(9):1263-1271. PubMed ID: 27776045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-148a inhibits cell proliferation and migration through targeting ErbB3 in colorectal cancer.
    Zhao W; Zheng J; Wei G; Yang K; Wang G; Sun X
    Oncol Lett; 2019 Sep; 18(3):2530-2536. PubMed ID: 31402949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
    Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-148a Suppresses estrogen-induced viability and migration of breast cancer cells via inhibition of estrogen receptor α expression.
    Ma F; Feng Y; Li W; Li Z; Liu T; Li L
    Exp Ther Med; 2017 May; 13(5):2515-2522. PubMed ID: 28565873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
    Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
    BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-148a promotes apoptosis and suppresses growth of breast cancer cells by targeting B-cell lymphoma 2.
    Li Q; Ren P; Shi P; Chen Y; Xiang F; Zhang L; Wang J; Lv Q; Xie M
    Anticancer Drugs; 2017 Jul; 28(6):588-595. PubMed ID: 28430743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
    Xu Q; Jiang Y; Yin Y; Li Q; He J; Jing Y; Qi YT; Xu Q; Li W; Lu B; Peiper SS; Jiang BH; Liu LZ
    J Mol Cell Biol; 2013 Feb; 5(1):3-13. PubMed ID: 22935141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
    Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-148a-3p Regulates Skeletal Muscle Satellite Cell Differentiation and Apoptosis via the PI3K/AKT Signaling Pathway by Targeting Meox2.
    Yin H; He H; Cao X; Shen X; Han S; Cui C; Zhao J; Wei Y; Chen Y; Xia L; Wang Y; Li D; Zhu Q
    Front Genet; 2020; 11():512. PubMed ID: 32582277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-148a suppresses invasion and induces apoptosis of breast cancer cells by regulating USP4 and BIM expression.
    Zhang L; Xing M; Wang X; Cao W; Wang H
    Int J Clin Exp Pathol; 2017; 10(8):8361-8368. PubMed ID: 31966687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-148a inhibits migration of breast cancer cells by targeting MMP-13.
    Xue J; Chen Z; Gu X; Zhang Y; Zhang W
    Tumour Biol; 2016 Feb; 37(2):1581-90. PubMed ID: 26298724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
    Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
    Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
    Lacerda JZ; Ferreira LC; Lopes BC; Aristizábal-Pachón AF; Bajgelman MC; Borin TF; Zuccari DAPC
    Microrna; 2019; 8(3):237-247. PubMed ID: 30806335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
    Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
    PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression.
    Fujita Y; Kojima K; Ohhashi R; Hamada N; Nozawa Y; Kitamoto A; Sato A; Kondo S; Kojima T; Deguchi T; Ito M
    J Biol Chem; 2010 Jun; 285(25):19076-84. PubMed ID: 20406806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.
    Wang SH; Li X; Zhou LS; Cao ZW; Shi C; Zhou CZ; Wen YG; Shen Y; Li JK
    Tumour Biol; 2013 Dec; 34(6):3705-12. PubMed ID: 23873106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9.
    Zhang BX; Yu T; Yu Z; Yang XG
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6497-6504. PubMed ID: 31378889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.